{"id":"W4391130620","doi":"10.1007/s40257-024-00846-3","title":"Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program","year":2024,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research","funders":"National Center for Advancing Translational Sciences; Pfizer","keywords":"Medicine; Placebo; Internal medicine; Alopecia areata; Adverse effect; Cohort; Gastroenterology; Incidence (geometry); Surgery; Dermatology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low","status":"direct model label, unvalidated"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low","status":"direct model label, unvalidated"}],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0149527,0.000656239,0.001691516,0.0008921017,0.0003547122,0.001225297,0.0006584373,0.0006681644,0.002446683],"category_scores_gemma":[0.007364588,0.0003110034,0.003126655,0.0007352119,0.0004169136,0.0006796615,0.0007072011,0.0009440167,0.0001979489],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009651253,"about_ca_system_score_gemma":0.00218338,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005114294,"about_ca_topic_score_gemma":0.001576319,"domain_scores_codex":[0.9935796,0.004013427,0.0003992855,0.000562372,0.001182833,0.0002624808],"domain_scores_gemma":[0.9907115,0.002823849,0.00400742,0.0005923031,0.001169318,0.0006955593],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5210551,0.005626989,0.1521688,0.006045849,0.05291517,0.0004726767,0.0003974537,0.005284694,0.02195149,0.0004275848,0.004064708,0.2295894],"study_design_scores_gemma":[0.1948331,0.2277901,0.4926742,0.000771603,0.04988242,0.001667717,0.0001333942,0.005045002,0.01006545,0.0006087703,0.01640572,0.0001226176],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9728968,0.01601141,0.002225666,0.0003629292,0.00004821362,0.002925855,0.003132673,0.00007841471,0.002318021],"genre_scores_gemma":[0.9896027,0.002535735,0.001647994,0.0003131653,0.0001199303,0.001193221,0.004021199,0.00001268819,0.0005533104],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0149527,"threshold_uncertainty_score":0.07907832,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1100982298020965,"score_gpt":0.4678687888651819,"score_spread":0.3577705590630854,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}